Hybrid nanopotentiators with dual cascade amplification for glioma combined interventional therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Glioma presents a poor prognosis due to challenges in chemotherapy, including poor tumor targeting and penetration.
• The tumor microenvironment poses a significant barrier to effective drug delivery and therapeutic outcomes in glioma treatment.

Purpose of the Study:

• To design and evaluate a core-shell structure cascade amplified hybrid catalytic nanopotentiator (CFpAD) for overcoming glioma therapeutic obstacles.
• To enhance glioma chemotherapy efficacy through improved tumor accumulation, penetration, and synergistic therapeutic effects.

Main Methods:

• Development of CFpAD nanoparticles encapsulating DM1, utilizing NIR laser for Blood-Brain Barrier (BBB) penetration.
• CFpAD triggers a cascade reaction releasing gold nanoparticles (GOx) and ferric oxide nanoparticles (FNPs) to produce reactive oxygen species (ROS).
• Combination of chemotherapy, interventional photothermal therapy (IPTT), and radiotherapy (RT) with starvation therapy.

Main Results:

• NIR laser enhanced BBB penetration and tumor accumulation of CFpAD.
• CFpAD triggered ROS production via cascade amplification, inducing tumor cell apoptosis.
• Significant decrease in glioma cell viability observed due to synergistic effects of DM1 chemotherapy, IPTT, RT, and starvation therapy.
• Gold nanoparticles reduced cancer-associated fibroblasts (CAFs) and extracellular matrix (ECM) secretion, improving CFpAD penetration.

Conclusions:

• The developed CFpAD system demonstrates effective overcoming of glioma therapeutic obstacles, including poor tumor targeting and penetration.
• The synergistic combination of cascade amplification, starvation therapy, IPTT, and RT shows outstanding antitumor efficacy.
• CFpAD represents a promising therapeutic system for glioma treatment with enhanced tumor penetration and significant antitumor effects.